Thor Medical ASA (TRMED) — Tangible Net Worth Ratio
Thor Medical ASA (TRMED) has a Tangible Net Worth Ratio of 42.2% as of June 2025. This metric is calculated by deducting intangible assets (Nkr273.60 Million) from net assets (Nkr473.50 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. See Thor Medical ASA net assets for net asset value and shareholders' equity analysis.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Thor Medical ASA Tangible Net Worth Ratio (2020–2024)
This chart shows how Thor Medical ASA's Tangible Net Worth Ratio has changed across 5 annual periods from 2020 to 2024. As of June 2025, the ratio stands at 42.2%, reflecting net assets of Nkr473.50 Million with intangible assets of Nkr273.60 Million NOK. Also explore net asset momentum of Thor Medical ASA to track the company's year-over-year net asset growth rate.
Annual Tangible Net Worth Ratio for Thor Medical ASA (2020–2024)
The table below presents the year-by-year Tangible Net Worth Ratio for Thor Medical ASA from 2020 to 2024, covering 5 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For the full company profile including market capitalisation, see Thor Medical ASA (TRMED) total market value.
| Year | Tangible NW Ratio | Net Assets (NOK) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 27.1% | Nkr337.10 Million | Nkr245.82 Million | Nkr414.40 Million | ▲ +18.0 pp |
| 2023 | 9.1% | Nkr271.93 Million | Nkr247.26 Million | Nkr330.83 Million | ▼ -90.9 pp |
| 2022 | 100.0% | Nkr63.84 Million | Nkr0.00 | Nkr109.64 Million | ▲ +0.0 pp |
| 2021 | 100.0% | Nkr140.52 Million | Nkr0.00 | Nkr296.67 Million | ▲ +0.0 pp |
| 2020 | 100.0% | Nkr178.67 Million | Nkr0.00 | Nkr314.61 Million | — |